Aerospace & Defense Consulting Services: From Bid Optimization to Fleet Availability

Monetizing Real-World Evidence (RWE)

The Trend
Payers no longer reimburse on clinical trial data alone — they demand proof of real-world efficacy before committing to premium pricing.

• Consequences on Growth
  Transitioning from one-time CAPEX sales to recurring OPEX revenue requires a total overhaul of sales incentives, contract management, and service delivery.
• Our Solution
  We design the digital frameworks that allow you to enter "Risk-Sharing" agreements with payers — from KPI definition (e.g., reduction in A1C levels, lower hospitalization rates) to automated EHR data capture, creating a single source of truth for both payer and provider.
• Financial Impact
  Outcome-based contracts protect premium pricing and secure "Preferred Brand" status with major hospital networks and payers.

The Hybrid Clinical Sales Engine

The Trend
The era of the "transactional rep" is over. Modern Life Sciences sales require a "Hybrid" model that combines deep clinical expertise with digital agility — yet most commercial organizations remain structured around outdated, activity-based models.

• Consequences on Growth
  Reps operating without clinical intelligence miss critical engagement windows. Over-reliance on physical presence limits scalability. And without C-Suite fluency, commercial teams are systematically excluded from strategic hospital purchasing decisions.
• Our Solution
  We transform your commercial force across three dimensions:
  • Clinical Consultant CRM — AI-driven dashboards delivering Next-Best-Action alerts, peer-reviewed content, and Value Calculators to reps in the field.
  • Virtual Proctoring & AR Training — Real-time remote surgical guidance via AR headsets and mobile-first On-Demand Training Portals for clinicians.
  • Visconti Leadership Coaching — C-Suite Engagement Training shifting commercial teams from activity-based to outcome-based KPIs.

• Financial Impact
   Higher physician engagement, reduced in-person support costs, greater access to hospital decision-makers, and a commercial culture aligned to outcomes. 

"Beyond the Pill" Digital Services

The Trend
The most successful Life Sciences firms are no longer just selling a product — they are selling a "Therapy Journey." Non-adherence, disconnected diagnostics, and untapped support infrastructure remain among the most costly challenges in the industry.

• Consequences on Growth
  Poor adherence undermines therapy outcomes, weakens RWE data quality, and erodes the commercial case for premium pricing. Without a DTx strategy, companies risk being outpaced by competitors offering more holistic solutions. Patient Support Programs remain trapped as cost centers rather than value drivers.
• Our Solution
  We design the full therapy ecosystem around your core molecule or device:
  • Patient Adherence & Companion Apps — behavioral science-powered apps combining Smart Reminders, Gamification, and Integrated Diagnostics for real-time therapy feedback.
  • DTx Integration — Combined Therapy Bundles (CBT + pharmacotherapy) and Provider Dashboards for real-time patient monitoring between visits.
  • Monetization of Support Services — Tiered Support Levels from standard digital care to premium "concierge" clinical support, plus Data-as-a-Service models feeding anonymized patient journey insights back to payers and R&D.
• Financial Impact
  Higher adherence rates, stronger RWE, bundled reimbursement opportunities, and Patient Support Programs transformed from budget lines into strategic revenue streams.